Clinical characteristics and prognostic factors in multiple myeloma patients with light chain deposition disease.

about

Clinical characteristics and prognostic factors in multiple myeloma patients with light chain deposition disease.

Item

http://www.wikidata.org/entity/Q48313100

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Clinical characteristics and p ...... ight chain deposition disease.

@en

Clinical characteristics and p ...... ight chain deposition disease.

@nl

type

Item

label

Clinical characteristics and p ...... ight chain deposition disease.

@en

Clinical characteristics and p ...... ight chain deposition disease.

@nl

prefLabel

Clinical characteristics and p ...... ight chain deposition disease.

@en

Clinical characteristics and p ...... ight chain deposition disease.

@nl

P1476

Clinical characteristics and p ...... light chain deposition disease

@en

P2093

Aasiya Matin

http://www.w3.org/2001/XMLSchema#string

Amy Buros

http://www.w3.org/2001/XMLSchema#string

Bart Barlogie

http://www.w3.org/2001/XMLSchema#string

Cynthia Davis

http://www.w3.org/2001/XMLSchema#string

Faith Davies

http://www.w3.org/2001/XMLSchema#string

Frits van Rhee

http://www.w3.org/2001/XMLSchema#string

Jorge Jo Kamimoto

http://www.w3.org/2001/XMLSchema#string

Joshua Epstein

http://www.w3.org/2001/XMLSchema#string

Meera Mohan

http://www.w3.org/2001/XMLSchema#string

Monica Grazziutti

http://www.w3.org/2001/XMLSchema#string

P2860

Treatment of light chain deposition disease with bortezomib and dexamethasone

Myeloablative chemotherapy with stem cell rescue for the treatment of primary systemic amyloidosis: a status report.

The molecular classification of multiple myeloma

Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients

Light chain deposition disease with renal involvement: clinical characteristics and prognostic factors.

Renal insufficiency retains adverse prognostic implications despite renal function improvement following Total Therapy for newly diagnosed multiple myeloma.

Natural history and outcome of light chain deposition disease.

Outcomes of patients with renal monoclonal immunoglobulin deposition disease.

Manifestations of systemic light chain deposition.

Reversibility of renal impairment in patients with multiple myeloma treated with bortezomib-based regimens: identification of predictive factors.

P304

739-745

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/AJH.24756

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28383130

http://www.w3.org/2001/XMLSchema#string